John L. Higgins - Sep 16, 2022 Form 4/A - Amendment Insider Report for LIGAND PHARMACEUTICALS INC (LGND)

Signature
By: Charles S. Berkman For: John L. Higgins
Stock symbol
LGND
Transactions as of
Sep 16, 2022
Transactions value $
-$88,060
Form type
4/A - Amendment
Date filed
9/22/2022, 08:32 PM
Date Of Original Report
Sep 16, 2022
Previous filing
Sep 16, 2022
Next filing
Oct 31, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LGND Common Stock Sale -$88.1K -1K -0.27% $88.06 366K Sep 16, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On September 16, 2022, due to an issue with the equity administration system of the company, the reporting person filed a Form 4 which inadvertently reported the sale of a higher number of shares than were actually sold by the reporting person. The correct number of shares sold is listed above.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.05 to $88.12, inclusive. The reporting person undertakes to provide, upon request to the Securities Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.